Sign In

Johnathan Matlock

Co-Founder @ Empirical Ventures | Scientist | Entrepreneur | Investor | PhD Chemistry

Professional Background

Johnathan Matlock is an accomplished entrepreneur and seasoned venture capitalist, currently serving as a co-founder at Empirical Ventures, a pioneering venture capital fund focused on pre-seed and seed investments in deep science startups throughout the UK. With a strong commitment to fostering innovation that addresses some of the most pressing global challenges, Johnathan, along with his team, successfully launched Fund I in March 2024, boasting an impressive £8.25 million in committed capital. This significant foundation not only underscores his deep understanding of the investment landscape but also highlights his ability to identify and back transformative technologies that can redefine industries.

In addition to his role at Empirical Ventures, Johnathan has built an extensive personal portfolio comprising 60 angel investments in deep science startups, as well as five limited partner (LP) commitments to emerging venture capital funds. His investment strategies emphasize the importance of creating value through scientific advancement and sustainable solutions.

Prior to establishing Empirical Ventures, Johnathan co-founded the Science Angel Syndicate in 2021, where he played a pivotal role in deploying £6.2 million into 15 innovative companies. His expertise in identifying high-potential startups within the deep science sector distinguishes him as a thought leader in the field.

Johnathan's impressive journey in the venture capital sphere is complemented by his board and advisory roles for several pioneering companies, enabling him to effectively mentor and guide founders towards achieving their strategic objectives.

Education and Achievements

Johnathan Matlock possesses a rich academic background that supports his distinguished career in venture capital and technology. He earned his Doctor of Philosophy (PhD) degree in Organic Chemistry from the esteemed University of Bristol, where he not only honed his research skills but also developed a robust understanding of material science and its applications in real-world scenarios. His educational journey began at the University of York, where he obtained a Master of Chemistry, laying the groundwork for his scientific expertise. His initial studies at William Bradford Community College further provide a robust foundation in chemistry and the essential skills required for advanced study.

Throughout his career, Johnathan has consistently demonstrated an aptitude for innovation and leadership. He played a crucial role at Ziylo, a university spin-out, in the development of the world's first glucose-sensitive insulin, a groundbreaking innovation that led to the acquisition of Ziylo by Novo Nordisk for an impressive £623 million. This achievement not only illustrates Johnathan's ability to contribute to groundbreaking advancements but also emphasizes his dedication to improving healthcare solutions.

Achievements

Johnathan's professional journey reflects a host of significant achievements that further underscore his expertise in the realm of science and venture capital. His commitment to sustainability and social impact is evident in his involvement with several advisory boards for venture capital funds that focus on decarbonisation and sustainable energy initiatives. Through these roles, he is actively contributing to the evolution of technologies that pave the way for a greener future.

As a respected figure in the venture capital community, Johnathan holds several board and advisory positions, showcasing his unparalleled commitment to fostering innovation and supporting the next generation of entrepreneurs. He has been a Board Observer and Advisor for various organizations, including QV Bioelectronics, CheMastery Group Ltd, Elbow Beach Capital, GenomeKey,ARGONAUTE RNA LIMITED, WASE LIMITED, Zentraxa, Anaphite, and Signum-Health Ltd. His comprehensive experience across diverse sectors positions him as a leading expert in the nexus of science and technology.

Johnathan Matlock is not only a successful entrepreneur and investor but also a proud advocate for the next generation of scientific innovation. His work reshaping venture capital investment in deep science and technology serves as an inspiring blueprint for current and aspiring entrepreneurs. With his in-depth knowledge, unwavering passion, and steadfast commitment to supporting groundbreaking innovations, he continues to drive impactful solutions that address the most critical challenges facing our society today.

Related Questions

How did Johnathan Matlock transition from a career in organic chemistry to venture capital?
What inspired Johnathan Matlock to co-found Empirical Ventures?
What strategies has Johnathan Matlock employed to achieve success in his 60 angel investments?
How does Johnathan Matlock identify promising deep science startups for investment?
What lessons has Johnathan Matlock learned from his experience developing glucose-sensitive insulin?
Johnathan Matlock
Add to my network

Location

Bedford, England, United Kingdom